BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

422 related articles for article (PubMed ID: 26629915)

  • 1. Comparative evaluation of antibacterial activity of caffeic acid phenethyl ester and PLGA nanoparticle formulation by different methods.
    Arasoglu T; Derman S; Mansuroglu B
    Nanotechnology; 2016 Jan; 27(2):025103. PubMed ID: 26629915
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Assessment of the Antigenotoxic Activity of Poly(d,l-lactic- co-glycolic acid) Nanoparticles Loaded with Caffeic Acid Phenethyl Ester Using the Ames Salmonella/Microsome Assay.
    Arasoğlu T; Derman S
    J Agric Food Chem; 2018 Jun; 66(24):6196-6204. PubMed ID: 29799193
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fabrication of Novel Bioactive Cellulose-Based Films Derived from Caffeic Acid Phenethyl Ester-Loaded Nanoparticles via a Rapid Expansion Process: RESOLV.
    Saelo S; Assatarakul K; Sane A; Suppakul P
    J Agric Food Chem; 2016 Sep; 64(35):6694-707. PubMed ID: 27548627
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antimicrobial activity of a new synthetic peptide loaded in polylactic acid or poly(lactic-co-glycolic) acid nanoparticles against Pseudomonas aeruginosa, Escherichia coli O157:H7 and methicillin resistant Staphylococcus aureus (MRSA).
    Cruz J; Flórez J; Torres R; Urquiza M; Gutiérrez JA; Guzmán F; Ortiz CC
    Nanotechnology; 2017 Mar; 28(13):135102. PubMed ID: 28266350
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antibacterial and antioxidant electrospun materials from poly(3-hydroxybutyrate) and polyvinylpyrrolidone containing caffeic acid phenethyl ester - "in" and "on" strategies for enhanced solubility.
    Ignatova M; Manolova N; Rashkov I; Markova N
    Int J Pharm; 2018 Jul; 545(1-2):342-356. PubMed ID: 29738797
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Enhanced antibacterial and antiparasitic activity of multifunctional polymeric nanoparticles.
    Durak S; Arasoglu T; Ates SC; Derman S
    Nanotechnology; 2020 Apr; 31(17):175705. PubMed ID: 31931488
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synthesis of hesperetin-loaded PLGA nanoparticles by two different experimental design methods and biological evaluation of optimized nanoparticles.
    Duranoğlu D; Uzunoglu D; Mansuroglu B; Arasoglu T; Derman S
    Nanotechnology; 2018 Sep; 29(39):395603. PubMed ID: 29972381
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Improved drug loading and antibacterial activity of minocycline-loaded PLGA nanoparticles prepared by solid/oil/water ion pairing method.
    Kashi TS; Eskandarion S; Esfandyari-Manesh M; Marashi SM; Samadi N; Fatemi SM; Atyabi F; Eshraghi S; Dinarvand R
    Int J Nanomedicine; 2012; 7():221-34. PubMed ID: 22275837
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Physicochemical and anti-bacterial performance characterization of clarithromycin nanoparticles as colloidal drug delivery system.
    Mohammadi G; Nokhodchi A; Barzegar-Jalali M; Lotfipour F; Adibkia K; Ehyaei N; Valizadeh H
    Colloids Surf B Biointerfaces; 2011 Nov; 88(1):39-44. PubMed ID: 21752610
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antibacterial and free-radical scavenging activities of Sonoran propolis.
    Velazquez C; Navarro M; Acosta A; Angulo A; Dominguez Z; Robles R; Robles-Zepeda R; Lugo E; Goycoolea FM; Velazquez EF; Astiazaran H; Hernandez J
    J Appl Microbiol; 2007 Nov; 103(5):1747-56. PubMed ID: 17953585
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synthesis, characterization and antibacterial activity of juglone encapsulated PLGA nanoparticles.
    Arasoglu T; Derman S; Mansuroglu B; Yelkenci G; Kocyigit B; Gumus B; Acar T; Kocacaliskan I
    J Appl Microbiol; 2017 Dec; 123(6):1407-1419. PubMed ID: 28980369
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of ciprofloxacin-loaded Eudragit RS100 or RL100/PLGA nanoparticles.
    Dillen K; Vandervoort J; Van den Mooter G; Ludwig A
    Int J Pharm; 2006 May; 314(1):72-82. PubMed ID: 16600538
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cefaclor Monohydrate-Loaded Colon-Targeted Nanoparticles for Use in COVID-19 Dependent Coinfections and Intestinal Symptoms: Formulation, Characterization, Release Kinetics, and Antimicrobial Activity.
    Alper Öztürk A; Namlı İ; Aygül A
    Assay Drug Dev Technol; 2021 Apr; 19(3):156-175. PubMed ID: 33728979
    [No Abstract]   [Full Text] [Related]  

  • 14. Study of Antimicrobial Effects of Clarithromycin Loaded PLGA Nanoparticles against Clinical Strains of Helicobacter pylori.
    Lotfipour F; Valizadeh H; Milani M; Bahrami N; Ghotaslou R
    Drug Res (Stuttg); 2016 Jan; 66(1):41-5. PubMed ID: 25919643
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Optimized protocols for assessing libraries of poorly soluble sortase A inhibitors for antibacterial activity against medically-relevant bacteria, toxicity and enzyme inhibition.
    Alharthi S; Ziora ZM; Moyle PM
    Bioorg Med Chem; 2021 Dec; 52():116527. PubMed ID: 34839159
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ciprofloxacin-encapsulated poly(DL-lactide-co-glycolide) nanoparticles and its antibacterial activity.
    Jeong YI; Na HS; Seo DH; Kim DG; Lee HC; Jang MK; Na SK; Roh SH; Kim SI; Nah JW
    Int J Pharm; 2008 Mar; 352(1-2):317-23. PubMed ID: 18160236
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antibacterial activity of clarithromycin loaded PLGA nanoparticles.
    Valizadeh H; Mohammadi G; Ehyaei R; Milani M; Azhdarzadeh M; Zakeri-Milani P; Lotfipour F
    Pharmazie; 2012 Jan; 67(1):63-8. PubMed ID: 22393833
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Targeted delivery of rifaximin using P6.2-decorated bifunctional PLGA nanoparticles for combating Staphylococcus aureus infections.
    Arayici PP; Coksu I; Ozbek T; Acar S
    Biomater Adv; 2024 Jul; 161():213862. PubMed ID: 38678666
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nanoparticle-mediated delivery of the antimicrobial peptide plectasin against Staphylococcus aureus in infected epithelial cells.
    Water JJ; Smart S; Franzyk H; Foged C; Nielsen HM
    Eur J Pharm Biopharm; 2015 May; 92():65-73. PubMed ID: 25701808
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Combined effects of Ag nanoparticles and oxygen plasma treatment on PLGA morphological, chemical, and antibacterial properties.
    Fortunati E; Mattioli S; Visai L; Imbriani M; Fierro JL; Kenny JM; Armentano I
    Biomacromolecules; 2013 Mar; 14(3):626-36. PubMed ID: 23360180
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.